Primary Venture Partners
386 Park Ave S, 14th Floor, New York, NY, 10016, United States
Overview
Early stage venture firm supporting founders to build unicorns.
Founded
2015
Deals · 12mo
21
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Etched.ai
Participated · Equity · Aug 2026
Etched.ai develops rack-scale inference systems and broader frontier inference infrastructure. Since founding, the company has grown to more than 400 employees, hiring over 200 people after its Series B late last year. It has secured more than $1 billion in customer orders and established deep manufacturing and supply-chain partnerships, including opening a factory in Taiwan. Etched is currently validating its first rack-scale inference product with customers. The company’s near-term plans emphasize production, manufacturing scale-up, and deployment of its inference systems, supported by cumulative funding of $800 million.
- Lantern
Led · Seed · Jul 2026
Lantern is focused on streamlining wholesale distribution, which its founders characterize as the central node of a $9 trillion supply-chain market. The company was founded by Matt Rojas and Conor Leen while they were students at Stanford GSB and later brought in Jayadeep Shitole as co-founder and CTO. Lantern conducted extensive customer discovery with wholesale distributors before launching and reportedly began operations in late fall. Since launch, investors have reported the company has been on an "incredible growth curve." Early support and workspace came from Pear VC, which led Lantern's pre-seed and participated in the seed round, with Primary Venture Partners leading the seed. The team emphasizes iterative product discovery and deep customer interviews as core to their approach.
- LightTable
Participated · Series A · May 2026
LightTable develops an AI-powered platform that performs peer review of real estate development documents. Its system processes PDFs including architectural plans and engineering specifications and delivers coordinated reviews covering constructability, mechanical, electrical, plumbing (MEP), accessibility, and fire and life safety. The platform generates a list of potential issues that could lead to change orders or construction delays. LightTable serves developers, architects, engineers, and general contractors. The company raised $6M in seed funding and intends to use the proceeds to expand operations and broaden its business reach. LightTable was founded in October 2024.
- Tokaido Health
Participated · Equity · May 2026
Tokaido Health provides AI-native medication steerage anchored in behavioral economics to counter incentive distortions in medication sourcing and administration. Its platform offers site-of-care steerage, biosimilar substitution, formulary optimization, and polypharmacy reconciliation, paired with loss-framed incentives to encourage members to switch to lower-cost options. The company layers its concierge services on top of existing benefits ecosystems and manages the operational work to make switching effortless for members. The announcement named the founding team and advisors and stated the company is hiring technical, clinical, operations, and sales staff. Tokaido disclosed $25 million committed from a group of investors to support building and scaling its product and team.
- Dandelion Health
Participated · Series A · May 2026
Dandelion Health develops a multimodal clinical AI platform intended to inform drug development and redesign clinical trial design using high-fidelity longitudinal clinical data. The company positions its platform to better characterize pre-disease windows and patient trajectories so trials are built against current clinical realities rather than outdated disease definitions. Leadership mentioned in the announcement includes Elliott Green and Niyum Gandhi, and the company has attracted investors with healthcare and scientific expertise. Financially, the company completed a $14 million Series A led by new investors Healthier Capital and Colle Capital alongside returning investors Primary Venture Partners, Moxxie Ventures, and Convergent Ventures. Dandelion says the new capital will be applied to continue developing its clinical-AI capabilities and expanding its platform's use in life sciences and AI development. The article does not disclose revenue, user, or other operating metrics.